GPX4 and Alzheimer disease: The first phase, from 2014 to 2017, highlights keywords like ‘cancer cells, death, injury, 12/15 lipoxygenase, glutamate, gpx4, biomolecules, AD’, focusing on physiological changes and disease effects.